Table 4 Change of lipid profiles from baseline at end-line (after 12-weeks intervention) by intervention group
Lipid profile parameters | FBR Group (Intervention, n=48) | Non FBR (Comparison, n=54) | Mean difference† (FBR - Non-FBR) ((lower; upper bound of 95% CI), p value* | ||||
|---|---|---|---|---|---|---|---|
Baseline¶ (SE) | End of trial¶ (SE) | Change from baseline¶ (Lower; upper bound of 95% CI), p-value* | Baseline¶ (SE) | End of trial¶ (SE) | Change from baseline¶ (Lower; upper bound of 95% CI), p-value* | ||
Total cholesterol, mg/dL | 221 (4.1) | 230 (3.9) | 12.5(7.0; 14.8), 0.006 | 207(4.9) | 222(4.6) | 15.5(10.5;20.6), 0.045 | -2.9(-9.7; 3.86), 0.391 |
LDL-cholesterol, mg/dL | 149 (3.9) | 155 (3.5) | 9.8(4.7;14.8), 0.033 | 135(4.3) | 150(4.2) | 14.6(4.7;14.8), 0.064 | -4.8(-11.1;1.4), 0.129 |
HDL-cholesterol, mg/dL | 44.2 (1.6) | 49.3(2.1) | 5.0(3.2;6.9), <0.001 | 46(1.2) | 50(1.7) | 4(1.9; 6.1), <0.001 | 0.4(-2.7;3.7), 0.767 |
Triglyceride, mean (SE), mg/dL) | 139 (12.8) | 122(11.5) | -16.9(-35.4; 1.9), 0.077 | 126(8.6) | 111(7.8) | -15.7(-26.3; -5.1);0.005 | -2.4(--26.8;21.9), 0.843 |
Catelli’s Index I(TC/HDL) | 5.0 (0.118) | 4.8(0.155) | -0.22(-0.4; -0.05), 0.011 | 4.57(0.13) | 4.47(0.18) | -0.1(-0.35;0.14); 0.397 | -0.19(-0.544; 0.167), 0.294 |
Catelli’s Index II(LDL/HDL) | 3.4 (0.10) | 3.3(0.13) | -0.11(-0.28;0.04), 0.147 | 2.9(0.11) | 2.9(0.16) | 0.001(-0.24; 0.24), 0.991 | -0.10(-0.56; 0.11), 0.178 |
Castelli’s index I > 4.5, n (%) | 33 (68.7) | 24(50.0) | -9(-18.7) | 28(51.9) | 20(37.0) | -8(-14.8) | n.a |
Decrease in Castelli’s Index, n (%) | n.a | 34(70.8) | n.a | n.a | 36(66.7) | n.a | n.a |